within Pharmacolibrary.Drugs.ATC.V;

model V09GA05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.008333333333333333,
    adminDuration  = 600,
    adminMass      = 0.555,
    adminCount     = 1,
    Vd             = 0.02,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Technetium (99mTc) furifosmin is a radiopharmaceutical agent primarily used for myocardial perfusion imaging in nuclear medicine. It is a lipophilic, cationic complex that accumulates in myocardial tissue and enables scintigraphic evaluation of coronary artery disease. It is approved and in current clinical use.</p><h4>Pharmacokinetics</h4><p>Estimated parameters for adult subjects; no published human pharmacokinetic parameters available. Typical values inferred based on Tc-99m radiopharmaceuticals and clinical guidance.</p><h4>References</h4><ol><li>M Rodriques, F Chehne, W Kalinowska, C Zielinski, H Sinzinger,Comparative 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin uptake in human soft tissue sarcoma cell lines.,European journal of nuclear medicine,2000<a href='https://pubmed.ncbi.nlm.nih.gov/11189948/'>https://pubmed.ncbi.nlm.nih.gov/11189948/</a></li><li>Wolfgang M Schaefer, Detlef Moka, Holger A Brockmann, Klaus Schomaecker, Harald Schicha,201Tl, 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin: relative retention and clearance kinetics in retrogradely perfused guinea pig hearts.,Nuclear medicine and biology,2002<a href='https://pubmed.ncbi.nlm.nih.gov/11823130/'>https://pubmed.ncbi.nlm.nih.gov/11823130/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V09GA05;
